CDC releases new resources to help identify MIS-C in children

The CDC released Sept. 20 new resources to help clinicians recognize multisystem inflammatory syndrome in children — a rare but serious immune response linked to COVID-19 infection — and communicate with parents about an MIS-C diagnosis. 

Advertisement

Symptoms usually appear within six weeks after a COVID-19 infection and commonly include ongoing fever, along with at least one of the following: stomach pain, diarrhea, vomiting, skin rash, bloodshot eyes, and dizziness or lightheadedness. 

If MIS-C is suspected, healthcare providers may conduct several tests, including blood tests, chest X-rays, heart ultrasound and abdominal ultrasound.  

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Public Health

Advertisement

Comments are closed.